Autor: Firma Tentamus Group

Techni’Sens joins the Tentamus Network!

Tentamus is thrilled to welcome Techni’Sens as its newest member of the global network of laboratories. Jérémy Picherit, CEO of Techni’Sens is excited: “it was our goal to find a strategic and international partner who follows a similar entrepreneurial spirit as we do. With Tentamus we found exactly that, which enables us to grow even […]

Read More

L.A.B. introduces in its multi-residue analysis the active ingredient Karanjin

L.A.B. | Laboratorio Analítico Bioclínico, fulfilling its commitment to its clients to improve its analytical services and in response to the recent requirement of the main supermarket chains and intermediaries, has introduced the active ingredient Karanjin in its multi-residue analysis. Karanjin is a type of flavonoid obtained from the seeds of the karanja tree (Millettia […]

Read More

Global Tea Testing by Tentamus

The primary source of tea is in Asia, but enjoyed worldwide. To ensure that the tea is also safe, Tentamus Group provides you with tea testing and consulting services in 3 continents: Asia, Europe and North America. You can choose testing at origin or point of export, or indeed for import and local area conformity. […]

Read More

New progress on the stability indexes for EVOOs

Laboratorio Tello together with L.A.B. (both part of Tentamus Group) and the University of Granada, continue to advance in the development of stability indices on extra virgin olive oils and other vegetable oils.  Since 2018, Laboratorio Tello and L.A.B. are working on the public research project CASEITE of the call “RETOS Colaboración 2017″ next to the Analytical Chemistry Research Group FQM-232 (Analysis in Food and Environment of UGR) focussing on the […]

Read More

FOOD & DRUG ANALYTICAL SERVICES LIMITED Announces Name Change to TENTAMUS PHARMA UK LIMITED

Food & Drug Analytical Services Limited (FDAS) has changed its name to Tentamus Pharma UK Limited.  This change marks five years following the successful acquisition by Tentamus Group GmbH. The new name better reflects the services and reflects the close relationship of the global Tentamus laboratory network. The Tentamus Group operates a worldwide network of […]

Read More

Thiamethoxam banned for use in the UK

Thiamethoxam, a neonicotinoid pesticide, was banned for use by both the UK and the EU back in 2018 due to the adverse effects on bee populations and other pollinators. In recent years it had been approved in the UK for emergency use due to the presence of yellow virus. Growers of sugar beet in particular […]

Read More

Precison Analysis NW LTD joins the Tentamus Network!

Together, Precision Analysis NW Ltd (Precision) and the Tentamus Group (Tentamus) are excited to announce the acquisition of Precision by Tentamus. Tentamus is thrilled to welcome Precision as its newest member to the global network of laboratories, on the 15th of March 2021. “Precision widens the northern UK expansion in the food and environmental testing market. […]

Read More

Adamson Analytical Expands Wine, Pesticides, and Cosmetic Testing Capabilities

Adamson Analytical has been diligently at work to meet client needs in an unpredictable and ever-changing environment. This past year was especially challenging given the worldwide pandemic and wildfires throughout California. With many vineyards and vintners left scrambling to salvage their product and determine the extent of fire damage, Adamson stepped up to the plate. […]

Read More

Tentamus launches its Spanish Website

The Tentamus Group is happy to announce the launch of the Tentamus website in Spanish featuring all analytical services and industries covered by Tentamus Group: Food & Feed, Agriculture & Environment, Pharmaceuticals & Medical Devices, Cosmetics as well as Agrosciences Services. The new website is aligned with the corporate identity of Tentamus Group and is […]

Read More

Risk evaluation of nitrosamines in pharmaceuticals

As of October 2020, EMA and the national competent authorities are asking marketing authorisation holders for metformin-containing medicines to test their medicines before releasing them onto the market. The risk evaluation for chemical medicines should be completed at the latest by 31 March 2021 and 1 July 2021 for biological medicines. If a risk is identified for an active substance, marketing authorisation holders […]

Read More